← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Idaho Veterans Research / Education Fdn
Boise, ID
$10,618,360
Total funding
15
Grants
Funding over time
peak $3.9M · FY2013–24$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$10,618,360 · 15
By mechanism
P20$9,403,516 · 9
R21$711,845 · 2
R03$263,525 · 2
R24$213,851 · 1
K01$25,623 · 1
Investigators at Idaho Veterans Research / Education Fdn
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Idaho Biomedical Research Collaborative in Emerging/Reemerging Infectious Disease$1,891,500
P20 · FY2018 · GM
Idaho Biomedical Research Collaborative in Emerging/Reemerging Infectious Disease$1,891,500
P20 · FY2019 · GM
Idaho Biomedical Research Collaborative in Emerging/Reemerging Infectious Disease$1,891,500
P20 · FY2020 · GM
Idaho Biomedical Research Collaborative in Emerging/Reemerging Infectious Disease$1,891,500
P20 · FY2017 · GM
Idaho Biomedical Research Collaborative in Emerging/Reemerging Infectious Disease$1,837,517
P20 · FY2016 · GM
Administrative Core$642,737
P20 · FY2018 · GM
Administrative Core$642,736
P20 · FY2019 · GM
Administrative Core$609,985
P20 · FY2017 · GM
Identification and Dynamics of SARS-CoV-2 Sequence Variants in Idaho$576,000
P20 · FY2021 · GM
Administrative Core$571,434
P20 · FY2020 · GM
Histology/Pathology/Imaging Core Facility$423,783
P20 · FY2016 · GM
Administrative Core$390,535
P20 · FY2016 · GM
Project 4: Role of Antecedent Influenza Infection in Severity and Outcome of Hemorrhagic MRSA Pneumonia$270,232
P20 · FY2017 · GM
Project 4: Role of Antecedent Influenza Infection in Severity and Outcome of Hemorrhagic MRSA Pneumonia$265,228
P20 · FY2019 · GM
Project 4: Role of Antecedent Influenza Infection in Severity and Outcome of Hemorrhagic MRSA Pneumonia$265,227
P20 · FY2018 · GM
Project 4: Role of Antecedent Influenza Infection in Severity and Outcome of Hemorrhagic MRSA Pneumonia$264,098
P20 · FY2016 · GM
Project 3: Innate Immune Responses to Group A Streptococcus in the Post-Partum Setting$261,344
P20 · FY2017 · GM
Project 2: Impact of Antibiotics on Growth Cycle and Toxin Production in S. aureus$258,505
P20 · FY2017 · GM
Project 1: Interplay of Toxins Driving and Augmenting C. difficile and C. sordellii Leukemoid Reactions (LR)$258,505
P20 · FY2017 · GM
Project 3: Innate Immune Responses to Group A Streptococcus in the Post-Partum Setting$255,353
P20 · FY2019 · GM